Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJet2 Regulatory News (JET2)

Share Price Information for Jet2 (JET2)

Share Price is delayed by 15 minutes
Get Live Data
1,283.00    32.00 (2.56%)
Bid:
1,282.00
Ask:
1,284.00
Spread: 2.00 (0.156%)
Market Cap: £2.32b
JET2 Live PriceLast checked at - London Stock Exchange

Intraday Jet2 Share Chart

Covid Corporate Financing Facility

12 Mar 2021 11:15

RNS Number : 1216S
Jet2 PLC
12 March 2021
 

12 March 2021

Jet2 plc ("Jet2", the "Group" or the "Company")

 

Covid Corporate Financing Facility

 

On 14 May 2020, the Company announced that it was confirmed as an eligible issuer under the Bank of England's Covid Corporate Financing Facility ("CCFF"). In October 2020, Her Majesty's Treasury ("HMT") amended the CCFF eligibility requirements to include, amongst other criteria, an updated investment grade requirement to reflect the impact of the pandemic. As a result, HMT has conducted a review process with the Company to ascertain whether it remains eligible for the CCFF.

With that process now complete, we are pleased to announce that Jet2 plc has been re-confirmed as an eligible issuer for the CCFF for up to £200m. The Company intends to issue the full amount of commercial paper through the CCFF prior to the closure of the scheme on 22 March 2021, which will be used to provide standby liquidity if required. 

 

Philip Meeson, Executive Chairman, commented:

"The Group is grateful to both the Bank of England and HM Treasury for the CCFF, the ongoing provision of the Coronavirus Job Retention Scheme and, together with the responsible liquidity actions already taken by the business, this provides the Group with additional headroom to deal with the ongoing cost of disruption to our sector, ensuring we can continue to support our great business through this challenging period.

 

Our liquidity position is strong - the Group's cash position as at 7 March 2021 (with the CCFF undrawn) comprised unaudited Total Cash of £1,189m and "Own Cash" of £892m (excluding advance customer deposits), having already proactively returned over £1.2bn of customer deposits since the start of the pandemic.

 

We have recently experienced a notable increase in bookings for Summer 2021 in line with the more recent positive news and though still early, we continue to be encouraged by the volume of our customer bookings for both Winter 21/22 and Summer 2022. Based on this limited visibility, we are confident that once normality returns, our Customers will be determined to enjoy the wonderful experience of a well-deserved Jet2 holiday and that Jet2.com and Jet2holidays will continue to have a thriving future, taking millions of UK holidaymakers annually, to the Mediterranean, the Canary Islands and to European Leisure Cities."

 

For further information, please contact:

 

Jet2 plc

Philip Meeson, Executive Chairman

Tel: 0113 239 7692

Gary Brown, Group Chief Financial Officer

Cenkos Securities plc - Nominated Adviser

Katy Birkin/Russell Cook

Tel: 020 7397 8900

Canaccord Genuity - Joint Broker

Adam James

Tel: 020 7523 8000

Jefferies International Limited - Joint Broker

Ed Matthews

Tel: 020 7029 8000

Buchanan - Financial PR

Richard Oldworth

Tel: 020 7466 5000

 

Certain of the information communicated in this announcement would have been deemed inside information for the purposes of Article 7 of the UK version of the EU Market Abuse Regulation (2014/596) which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended and supplemented from time to time, until the release of this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDKBBDDBKDNND
Date   Source Headline
1st Jun 20267:00 amRNSTotal Voting Rights
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSTotal Voting Rights
29th Apr 20267:00 amRNSTrading Update
28th Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20268:30 amRNSTotal Voting Rights
31st Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20264:04 pmRNSDirector/PDMR Shareholding
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20264:04 pmRNSDirector/PDMR Shareholding
2nd Mar 20268:30 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20264:58 pmRNSTR1: Notification of Major Holdings
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:01 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTrading Update
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20267:00 amRNSTransaction in Own Shares
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20265:55 pmRNSDirector/PDMR Shareholding
18th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20268:30 amRNSTotal Voting Rights
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.